The Reina Sofia Foundation acquires Europe’s first MAGNETOM Cima.X, the most powerful magnetic resonance imaging scanner on the market.

MAGNETOM Cima.X is a next-generation MRI system that promises to revolutionize clinical care and open new horizons in medical research.

The Reina Sofia Foundation, with the support of an important external partner, has acquired Europe’s first MAGNETOM Cima.X device, an innovative next-generation magnetic resonance system developed by Siemens Healthineers that promises to revolutionize clinical care and open new frontiers in the field of medicine. medical research. This MRI will be used by the Alzheimer’s Center of the Reina Sofia Foundation and transferred to CIEN (Research Center for Neurodegenerative Diseases) to continue collaboration with research into neurodegenerative diseases, mainly Alzheimer’s disease. Equipped with the most advanced technologies on the market, MAGNETOM Cima.X is designed to provide unparalleled image quality and improve diagnostic accuracy in modern medicine.

In a press presentation held at the Alzheimer’s Center of the Reina Sofia Foundation, experts explained that “the quality of an MRI scan is determined by two important factors: the strength of the magnetic field and the strength of its gradients. In particular, MAGNETOM Cima.X stands out with its 3 Tesla magnet and Gemini gradients, the most powerful available on the market. This combination allows us to obtain images of exceptional clarity and detail, resulting in ultra-precise and non-invasive images of the internal organs of the human body. In addition, the system includes deep learning algorithms based on patented Deep Resolve technology, which optimizes performance and improves the visualization of the smallest structures.”

CIEN supports, promotes and coordinates research in all areas of neuroscience.

Currently, neuroimaging methods constitute one of the areas of greatest progress in understanding various aspects of Alzheimer’s disease and other neurodegenerative pathologies: etiological diagnosis, early and differential diagnosis, functioning of brain regions, metabolism, neurotransmission.

CIEN stands out for its experience in bringing together and coordinating renowned Spanish research groups supporting, promoting and coordinating research in all areas of basic, clinical and epidemiological neuroscience, with a special focus on neurodegenerative diseases, mainly Alzheimer’s disease, the most common form of neurology. dementia. Thanks to this important milestone in the ongoing collaboration that the Reina Sofia Foundation provides to CIEN research, these specialists are now uniquely equipped to enable them to continue their research into the early diagnosis of neurodegenerative diseases in general and Alzheimer’s disease in particular, transforming clinical care and treatment. paving the way for innovative discoveries and clinical applications.

Important collaborations to improve health care and research in neurodegenerative diseases.

According to CIEN Scientific Director Dr. Pascual Sánchez Juan: “CIEN’s core research focus is precision medicine in neurodegenerative diseases. MAGNETOM Cima.X is a tool that will allow us to study our patients and volunteers in an unprecedented level of detail. This will allow us to explore the potential of MRI as a biomarker in different clinical scenarios; from early diagnosis to correlation with post-mortem studies or with new ultra-sensitive blood biomarkers. “The evidence obtained will help us position MRI in the new scenario that is opening up with the advent of modification treatments for Alzheimer’s disease.”

According to Alberto Martinez, CEO of Siemens Healthineers, MAGNETOM Cima.X marks a milestone in the research and diagnosis of neurodegenerative diseases, so CIEN Foundation specialists will now be able to push the boundaries of clinical research and generate new knowledge that will make a difference in patient care. “This collaboration with the CIEN Foundation is an important step towards improving care and research in neurodegenerative diseases. Our engineers have developed a completely new technical principle for MRI. MAGNETOM Cima.X is a testament to our commitment to excellence and innovation in healthcare,” he concluded.